Literature DB >> 16912934

No association between hepatitis C virus seropositivity and acute myocardial infarction.

Christine M Arcari1, Kenrad E Nelson, Dale M Netski, F Javier Nieto, Charlotte A Gaydos.   

Abstract

Recent studies have linked hepatitis C virus (HCV) infection with carotid atherosclerosis. We investigated the association between HCV seropositivity and acute myocardial infarction using a well-established cohort of young men in the US military and found no evidence to support this association.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16912934     DOI： 10.1086/507031

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  29 in total

1.  Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study.

Authors:  K A Forde; K Haynes; A B Troxel; S Trooskin; M T Osterman; S E Kimmel; J D Lewis; V Lo Re
Journal:  J Viral Hepat       Date:  2011-11-13       Impact factor: 3.728

Review 2.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  Metabolic Manifestations and Complications Associated With Chronic Hepatitis C Virus Infection.

Authors:  Robert J Wong; Robert G Gish
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-05

4.  Higher Prevalence and More Severe Coronary Artery Disease in Hepatitis C Virus-infected Patients: A Case Control Study.

Authors:  Sanjaya K Satapathy; Yun Ju Kim; Ashish Kataria; Arash Shifteh; Rohan Bhansali; Maurice A Cerulli; David Bernstein
Journal:  J Clin Exp Hepatol       Date:  2013-06-11

5.  The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C.

Authors:  Matthew S Freiberg; Chung-Chou H Chang; Melissa Skanderson; Kathleen McGinnis; Lewis H Kuller; Kevin L Kraemer; David Rimland; Matthew B Goetz; Adeel A Butt; Maria C Rodriguez Barradas; Cynthia Gibert; David Leaf; Sheldon T Brown; Jeffrey Samet; Lewis Kazis; Kendall Bryant; Amy C Justice
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-06-28

6.  Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors.

Authors:  Anne M Guiltinan; Zhanna Kaidarova; Brian Custer; Jennie Orland; Angela Strollo; Sherri Cyrus; Michael P Busch; Edward L Murphy
Journal:  Am J Epidemiol       Date:  2008-01-17       Impact factor: 4.897

Review 7.  Dysmetabolic changes associated with HCV: a distinct syndrome?

Authors:  Amedeo Lonardo; Paola Loria; Nicola Carulli
Journal:  Intern Emerg Med       Date:  2008-02-15       Impact factor: 3.397

Review 8.  Lipid dysregulation in hepatitis C virus, and impact of statin therapy upon clinical outcomes.

Authors:  Tracey G Simon; Adeel A Butt
Journal:  World J Gastroenterol       Date:  2015-07-21       Impact factor: 5.742

9.  Hepatitis C virus G1b infection decreases the number of small low-density lipoprotein particles.

Authors:  Chika Kinoshita; Tomohisa Nagano; Nobuyoshi Seki; Yoichi Tomita; Tomonori Sugita; Yuta Aida; Munenori Itagaki; Kenichi Satoh; Satoshi Sutoh; Hiroshi Abe; Akihito Tsubota; Yoshio Aizawa
Journal:  World J Gastroenterol       Date:  2016-08-07       Impact factor: 5.742

Review 10.  Hepatitis C virus infection and coronary artery disease risk: a systematic review of the literature.

Authors:  Robert J Wong; Fasiha Kanwal; Zobair M Younossi; Aijaz Ahmed
Journal:  Dig Dis Sci       Date:  2014-06-04       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.